CN101365458A - 用于铁给药的方法和组合物 - Google Patents
用于铁给药的方法和组合物 Download PDFInfo
- Publication number
- CN101365458A CN101365458A CNA2007800020060A CN200780002006A CN101365458A CN 101365458 A CN101365458 A CN 101365458A CN A2007800020060 A CNA2007800020060 A CN A2007800020060A CN 200780002006 A CN200780002006 A CN 200780002006A CN 101365458 A CN101365458 A CN 101365458A
- Authority
- CN
- China
- Prior art keywords
- ferrum
- complex
- carbohydrate
- iron
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
AB | 总共:32VIT-45:24总共:6VIT-45:6 | 100mg单剂量经由快速浓注500mg、800mg、1000mg在250mL Nss中稀释,通过IV输注15分钟给药100mg单剂量,用53Fe和59Fe标记的,通过IV注射10分钟给药 | 安慰剂无 |
CD | 总共:352VIT-45:174总共:344 | 计算每个患者的累积总铁需求。患者接受IV输注以每次输注给予最大剂量1000mg铁。患者每周接受一次VIT-45输注直至达到计算的累积剂量或者已经给予了最多2500mg。剂量≤200mg,作为IV推注液给药1-2分钟;300-400mg剂量,在100cc NsS中稀释并且给药6分钟;500-1、000mg剂量在250cc Nss中稀释并且给药15分钟。使用Ganzoni公式来计算每名患者的累积总铁 | 口服铁(硫酸亚铁)325mg TID,6周口服铁(硫酸亚铁) |
Claims (19)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75711906P | 2006-01-06 | 2006-01-06 | |
US60/757,119 | 2006-01-06 | ||
PCT/US2007/000176 WO2007081744A2 (en) | 2006-01-06 | 2007-01-08 | Methods and compositions for administration of iron |
US11/620,986 | 2007-01-08 | ||
US11/620,986 US7754702B2 (en) | 2006-01-06 | 2007-01-08 | Methods and compositions for administration of iron |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101365458A true CN101365458A (zh) | 2009-02-11 |
CN101365458B CN101365458B (zh) | 2012-09-05 |
Family
ID=38233459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007800020060A Ceased CN101365458B (zh) | 2006-01-06 | 2007-01-08 | 用于铁给药的方法和组合物 |
Country Status (11)
Country | Link |
---|---|
US (11) | US7754702B2 (zh) |
EP (3) | EP1973549B1 (zh) |
KR (4) | KR20140117678A (zh) |
CN (1) | CN101365458B (zh) |
AU (1) | AU2007205167B2 (zh) |
CA (2) | CA2635894C (zh) |
CY (1) | CY1118780T1 (zh) |
DK (1) | DK1973549T3 (zh) |
HK (1) | HK1125044A1 (zh) |
PT (1) | PT1973549T (zh) |
WO (1) | WO2007081744A2 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102153651A (zh) * | 2011-01-21 | 2011-08-17 | 厦门大学 | 抗葡聚糖单链抗体及其制备方法 |
CN102947321A (zh) * | 2010-06-09 | 2013-02-27 | 倍尔福股份公司 | 铁与麦芽糖酸的新型低分子量配合物、其在治疗贫血症状中用于肌肉或皮下给药的应用以及适于该应用的新型药剂组合物 |
US20150297630A1 (en) | 2006-01-06 | 2015-10-22 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
CN105616372A (zh) * | 2016-01-28 | 2016-06-01 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁片剂 |
CN105708792A (zh) * | 2016-01-28 | 2016-06-29 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁注射液及其制备方法 |
CN105708805A (zh) * | 2016-01-28 | 2016-06-29 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁及其制备方法 |
CN105726569A (zh) * | 2016-03-02 | 2016-07-06 | 东南大学 | 聚糖超顺磁氧化铁在制备治疗心血管疾病药物方面的应用 |
US10414831B2 (en) | 2009-03-25 | 2019-09-17 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US20060116349A1 (en) * | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
EP1790356A1 (de) * | 2005-11-24 | 2007-05-30 | Vifor (International) Ag | Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en) |
AU2008353469B2 (en) * | 2008-03-28 | 2014-12-11 | Chyna Llc | Use of ferritin to treat iron deficiency disorders |
GB0808835D0 (en) * | 2008-05-15 | 2008-06-18 | Vitra Pharmaceuticals Ltd | Therapeutic compositions |
EP2296998A1 (en) * | 2008-05-23 | 2011-03-23 | Hospira, Inc. | Packaged iron sucrose products |
CN105902482A (zh) * | 2008-06-25 | 2016-08-31 | Fe3医学有限公司 | 用于经皮递送治疗有效量的铁的贴片和方法 |
KR101017432B1 (ko) * | 2008-11-06 | 2011-02-28 | (주)유케이케미팜 | 함당산화철 제조방법 |
US8058076B2 (en) * | 2009-03-31 | 2011-11-15 | Astron Research Limited | In-vitro method for testing bioequivalence of iron-sucrose formulation |
US8821945B2 (en) | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
MX2012000892A (es) | 2009-07-21 | 2012-06-01 | Keryx Biopharmaceuticals Inc | Formas de dosificacion de citrato ferrico. |
EP2420243A1 (en) | 2010-08-18 | 2012-02-22 | Inovativo Biomedicinas Tehnologiju Instituts, SIA | Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming |
CN102451185A (zh) | 2010-10-19 | 2012-05-16 | 长春纳米生技公司 | 金属离子纳米簇组合物 |
WO2012092628A2 (en) * | 2010-12-31 | 2012-07-05 | Incube Labs, Llc | Patches and methods for the transdermal delivery of agents to treat hair loss |
ES2650918T3 (es) | 2011-12-30 | 2018-01-23 | Sloiron, Inc. | Procedimientos de aislamiento, uso y análisis de ferritina |
PL3730136T3 (pl) * | 2012-06-21 | 2024-03-25 | Keryx Biopharmaceuticals, Inc. | Zastosowanie cytrynianu żelaza(iii) w leczeniu pacjentów z przewlekłą chorobą nerek |
EP2877848A4 (en) * | 2012-07-27 | 2016-03-23 | Intrinsic Life Sciences Llc | METHOD FOR TREATING FERMENTED ANEMIA |
KR102218494B1 (ko) | 2013-03-15 | 2021-02-19 | 인트린식 라이프사이언시스, 엘엘씨 | 항-헵시딘 항체 및 그의 용도 |
US9370202B2 (en) | 2013-03-15 | 2016-06-21 | LG Bionano, LLC | Encapsulated metal ion nanoclusters |
JP6049194B2 (ja) * | 2013-03-28 | 2016-12-21 | 富士フイルム株式会社 | グラフ表示装置およびグラフ表示装置の作動方法並びにグラフ表示プログラム |
ES2856261T3 (es) | 2013-10-01 | 2021-09-27 | Fresenius Medical Care Deutschland Gmbh | Método y aparatos para determinar una pérdida diaria de hierro de un paciente |
KR101536325B1 (ko) * | 2013-10-16 | 2015-07-14 | 주식회사 지니스 | 전자기파를 이용한 암 온열치료용 감작제 조성물 및 이를 이용한 암 치료 방법 |
KR20150078375A (ko) * | 2013-12-30 | 2015-07-08 | 한화케미칼 주식회사 | 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물 |
TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
EP3197915A4 (en) | 2014-09-22 | 2018-12-19 | Intrinsic Lifesciences LLC | Humanized anti-hepcidin antibodies and uses thereof |
EP2913054A1 (en) * | 2015-03-19 | 2015-09-02 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of restless leg syndrome (rls) |
WO2016196274A1 (en) * | 2015-05-29 | 2016-12-08 | Luitpold Pharmaceuticals, Inc. | Compositions and methods for treatment of fibromyalgia |
EP3310364B1 (en) | 2015-06-22 | 2021-09-15 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant |
CA2932075C (en) * | 2015-09-01 | 2020-11-17 | Particle Dynamics International, Llc | Iron-polysaccharide complexes and methods for the preparation thereof |
US10258647B2 (en) | 2015-09-01 | 2019-04-16 | Particle Dynamics International, Llc | Iron-polysaccharide complexes and methods for the preparation thereof |
US20180296595A1 (en) * | 2015-09-11 | 2018-10-18 | Memorial Sloan Kettering Cancer Center | Methods and compositions for cancer treatment |
CN105520955B (zh) * | 2015-12-21 | 2018-05-11 | 南京生命能科技开发有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
WO2019152618A1 (en) * | 2018-01-31 | 2019-08-08 | University Of Maryland, Baltimore | A comprehensive method to quantify iron distribution in plasma |
BR112021008142A2 (pt) | 2018-10-29 | 2021-08-03 | Pharmacosmos Holding A/S | tratamento de deficiência de ferro com carboximaltose férrica |
US11726049B2 (en) * | 2020-05-04 | 2023-08-15 | Amphastar Pharmaceuticals, Inc. | Small angle x-ray scattering methods for characterizing the iron core of iron carbohydrate colloid drug products |
CN115364114B (zh) * | 2021-05-21 | 2023-12-01 | 武汉科福新药有限责任公司 | 羧基麦芽糖铁药用组合物及其制备方法 |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE370194C (de) | 1923-02-28 | Therese Rocksch Geb Laschet | Elektrolytisches Zinnbad zur Darstellung schwammfreier Zinnkristalle | |
CA623411A (en) | 1961-07-04 | Muller Arthur | Process for the manufacture of iron-polyisomaltose complex for therapeutical purposes | |
US1199951A (en) | 1915-11-06 | 1916-10-03 | Robert E Leigh | Lubricating device. |
CH123744A (de) | 1925-09-04 | 1927-12-16 | Anode Rubber Company Limited | Verfahren zur Herstellung von homogenen Niederschlägen aus wässerigen Dispersionen kautschukartiger Stoffe auf metallischen Niederschlagungsunterlagen. |
GB335965A (en) | 1929-06-05 | 1930-10-06 | Ig Farbenindustrie Ag | Process for the manufacture of complex iron compounds |
US2807610A (en) | 1952-02-15 | 1957-09-24 | Baker Chem Co J T | Hydrogenated dextran |
GB748024A (en) | 1953-02-27 | 1956-04-18 | Benger S Ltd | Improved therapeutic preparations of iron |
GB879441A (en) | 1959-05-25 | 1961-10-11 | Crookes Lab Ltd | Improved injectable iron preparations |
US3065138A (en) | 1959-10-09 | 1962-11-20 | Warren Teed Products Company | Therapeutic preparations of elemental iron |
US3100202A (en) * | 1960-06-17 | 1963-08-06 | Muller Arthur | Process for preparing an iron hydroxide polyisomaltose complex and the resulting product |
US3151107A (en) | 1960-12-22 | 1964-09-29 | Central Pharmacal Company | Water-soluble iron complexes of carboxymethyl dextran |
US3076798A (en) | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
GB985206A (en) | 1961-12-20 | 1965-03-03 | Hausmann Ag Labor | Improvements in or relating to therapeutic iron preparation |
ES282099A1 (es) | 1962-11-02 | 1963-01-01 | Rocador Sa | Procedimiento para la preparación de un complejo de óxido de hierro y ácidos dextránicos |
FR1451203A (fr) | 1964-01-31 | 1966-01-07 | Rocador Sa | Procédé pour la fabrication d'un complexe d'oxyde ferrique et de polysaccharide |
GB1183940A (en) | 1966-10-22 | 1970-03-11 | Fisons Pharmaceuticals Ltd | Ferric Hydroxide Complexes |
US3639588A (en) | 1966-10-22 | 1972-02-01 | Fisons Pharmaceuticals Ltd | Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids |
GB1199951A (en) | 1967-05-13 | 1970-07-22 | Fisons Pharmaceuticals Ltd | Modified Dextran and Derivatives Thereof |
GB1200902A (en) | 1967-05-13 | 1970-08-05 | Fisons Pharmaceuticals Ltd | Iron-dextran complexes |
US3395229A (en) | 1967-07-03 | 1968-07-30 | Mattox And Moore Inc | Process and product for combatting iron deficiency anemia in suckling pigs |
US3821192A (en) | 1971-08-18 | 1974-06-28 | Central Pharmacal Co | Process for preparing an iron-saccharide complex |
SE359447B (zh) | 1971-10-06 | 1973-09-03 | Astra Laekemedel Ab | |
US3928581A (en) | 1972-09-13 | 1975-12-23 | Astra Laekemedel Ab | Certain polymer-iron complexes for treatment of iron deficiency |
US3965133A (en) | 1972-10-04 | 1976-06-22 | Astra Lakemedel Aktiebolag | Polymer |
US3969395A (en) | 1972-10-04 | 1976-07-13 | Astra Lakemedel Aktiebolag | Polymers of hydroxy carboxylic acid and a polyhydric alcohol |
US4056672A (en) | 1973-03-22 | 1977-11-01 | Astra Lakemedel Aktiebolag | Polymer prepared by cyanhydrin method |
JPS6039681B2 (ja) | 1976-01-01 | 1985-09-07 | 日本臓器製薬株式会社 | デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤 |
US4180567A (en) | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
US4370476A (en) | 1979-07-17 | 1983-01-25 | Usher Thomas C | Dextran polycarboxylic acids, ferric hydroxide complexes |
DE3026868C2 (de) | 1980-07-16 | 1986-03-13 | Laboratorien Hausmann AG, St. Gallen | Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung |
US4335116A (en) | 1980-10-07 | 1982-06-15 | University Patents, Inc. | Mineral-containing therapeutic compositions |
EP0051707A1 (en) | 1980-11-12 | 1982-05-19 | Thomas Clemens Usher | Dextran polycarboxylic acids, ferric hydroxide complexes thereof, pharmaceutical compositions containing them and methods for their manufacture |
US4788281A (en) | 1984-01-04 | 1988-11-29 | Tosoni Anthony L | Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof |
US4689235A (en) | 1984-01-31 | 1987-08-25 | Scm Corporation | Encapsulation matrix composition and encapsulate containing same |
US4612284A (en) | 1984-09-28 | 1986-09-16 | A. E. Staley Manufacturing Company | Process for the enzymatic hydrolysis of non-gelatinized granular starch material directly to glucose |
US5160726A (en) | 1990-02-15 | 1992-11-03 | Advanced Magnetics Inc. | Filter sterilization for production of colloidal, superparamagnetic MR contrast agents |
US5102652A (en) | 1986-07-03 | 1992-04-07 | Advanced Magnetics Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
JP2858752B2 (ja) | 1987-04-10 | 1999-02-17 | オーソ・フアーマシユーチカル・コーポレーシヨン | 正常な哺乳動物のヘマトクリツト値の増大方法 |
GB8902894D0 (en) | 1989-02-09 | 1989-03-30 | Fisons Plc | Compositions |
JP2726520B2 (ja) | 1989-10-20 | 1998-03-11 | 名糖産業株式会社 | 有機磁性複合体 |
AU652060C (en) | 1991-06-11 | 2004-04-22 | Meito Sangyo Kabushiki Kaisha | Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide |
TW293036B (zh) | 1992-11-27 | 1996-12-11 | Takeda Pharm Industry Co Ltd | |
EP0634174A1 (en) | 1993-07-13 | 1995-01-18 | Takeda Chemical Industries, Ltd. | Antianemic composition for veterinary use |
US5624668A (en) * | 1995-09-29 | 1997-04-29 | Luitpold Pharmaceuticals, Inc. | Iron dextran formulations |
EP0859795B1 (en) | 1995-11-09 | 2003-04-02 | Abbott Laboratories | Process for making crystalline iron dextran |
US5756715A (en) | 1996-11-08 | 1998-05-26 | Abbott Laboratories | Process for making crystalline iron dextran |
CA2195283C (en) | 1997-01-16 | 2008-07-22 | Thomas C. Usher | Process for manufacturing iron dextran using ultrafiltration |
US6219440B1 (en) | 1997-01-17 | 2001-04-17 | The University Of Connecticut | Method and apparatus for modeling cellular structure and function |
US6010719A (en) | 1997-09-16 | 2000-01-04 | Universiteit Gent | Freeze-dried disintegrating tablets |
DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
DE19833548A1 (de) | 1998-07-25 | 2000-02-03 | Messer Griesheim Gmbh | Überkritische Fluorierung |
US6587550B2 (en) | 1998-09-02 | 2003-07-01 | Michael O. Council | Method and apparatus for enabling a fee to be charged to a party initiating an electronic mail communication when the party is not on an authorization list associated with the party to whom the communication is directed |
DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
JP5064612B2 (ja) | 1999-04-09 | 2012-10-31 | エーエムエージー ファーマシューティカルズ,インコーポレイテッド | 還元された炭水化物類及び炭水化物誘導体で被覆された熱的に安定なコロイド状酸化鉄 |
US6495177B1 (en) | 1999-08-13 | 2002-12-17 | Warner Chilcott Laboratories Ireland Limited | Orally dissolvable nutritional supplement |
AT500063A1 (de) | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
US20020119174A1 (en) | 2000-07-26 | 2002-08-29 | Gardlik John Michael | Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates |
AU2002220280A1 (en) | 2000-12-07 | 2002-06-18 | Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj | Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
JP2002260951A (ja) | 2000-12-28 | 2002-09-13 | Denso Corp | 積層型誘電素子及びその製造方法,並びに電極用ペースト材料 |
US20030023208A1 (en) | 2001-07-24 | 2003-01-30 | Osypka Thomas P. | Apparatus for vascular access |
EP1492821B1 (en) | 2002-04-09 | 2006-08-02 | Pharmacosmos Holding A/S | Iron dextrin compounds for the treatment of iron deficiency anaemia |
WO2004000368A1 (en) | 2002-06-21 | 2003-12-31 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
DE10249552A1 (de) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US6960571B2 (en) | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
US20060116349A1 (en) | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
JP2007509974A (ja) | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | 3−アミノプロピル−n−ブチルホスフィン酸の増大した吸収のための組成物および薬用量形態 |
US20060134227A1 (en) | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
SI1848446T1 (sl) | 2005-02-09 | 2010-01-29 | Vifor Int Ag | Uporaba Ĺľelezove(III)-kompleksne spojine |
EP1757299A1 (de) | 2005-08-25 | 2007-02-28 | Vifor (International) Ag | Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung |
DK1973549T3 (en) | 2006-01-06 | 2016-11-21 | Vifor (International) Ag | Methods and compositions for administration of the iron |
US8778878B2 (en) | 2007-01-29 | 2014-07-15 | Chyna, LLC | Use of ferritin to treat iron disorders |
US8071542B2 (en) | 2007-01-29 | 2011-12-06 | Chyna, LLC | Use of ferritin to treat iron deficiency disorders |
EP2155850B1 (en) | 2007-05-18 | 2014-04-16 | Raffinerie Notre Dame - Orafti S.A. | Method for providing fragrance to a substrate; fragrance-containing substrate |
EP1997833A1 (de) | 2007-05-29 | 2008-12-03 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
FR2934272B1 (fr) | 2008-07-24 | 2013-08-16 | Roquette Freres | Procede de preparation de compositions a base de matiere amylacee et de polymere synthetique. |
HUE030866T2 (en) | 2009-03-25 | 2017-06-28 | Pharmacosmos Holding As | Stable iron-oligosaccharide compound |
FR2951177B1 (fr) | 2009-10-09 | 2012-12-21 | Roquette Freres | Procede de preparation de derives acetyles de matiere amylacee |
US20120214986A1 (en) | 2009-11-04 | 2012-08-23 | Symed Labs Limited | Process for the preparation of iron (iii) carboxymaltose complex |
US9120838B2 (en) | 2011-04-18 | 2015-09-01 | Curators Of The University Of Missouri | Saccharide conjugates |
EP2877848A4 (en) | 2012-07-27 | 2016-03-23 | Intrinsic Life Sciences Llc | METHOD FOR TREATING FERMENTED ANEMIA |
CA2889855A1 (en) | 2012-11-01 | 2014-05-08 | Robert S. Katz | Methods for treating fibromyalgia |
CN104918486B (zh) | 2012-11-30 | 2017-12-15 | 法玛科思莫斯股份公司 | 冷冻保护试剂,冷冻保护和冷冻保存的组合物,其用途,和冷冻保存方法 |
CN107438626A (zh) | 2015-03-23 | 2017-12-05 | 苏文生命科学有限公司 | 水溶性三价铁碳水化合物复合物的制备 |
WO2016181195A1 (en) | 2015-05-08 | 2016-11-17 | Suven Life Sciences Limited | Improved process for water soluble iron carbohydrate complexes |
EP3339329A1 (en) | 2016-12-22 | 2018-06-27 | LEK Pharmaceuticals d.d. | Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes |
-
2007
- 2007-01-08 DK DK07716309.5T patent/DK1973549T3/en active
- 2007-01-08 CA CA2635894A patent/CA2635894C/en not_active Expired - Fee Related
- 2007-01-08 KR KR1020147024469A patent/KR20140117678A/ko not_active Application Discontinuation
- 2007-01-08 EP EP07716309.5A patent/EP1973549B1/en not_active Revoked
- 2007-01-08 CA CA2953964A patent/CA2953964A1/en not_active Withdrawn
- 2007-01-08 AU AU2007205167A patent/AU2007205167B2/en active Active
- 2007-01-08 KR KR1020177005732A patent/KR101905340B1/ko active IP Right Grant
- 2007-01-08 PT PT77163095T patent/PT1973549T/pt unknown
- 2007-01-08 US US11/620,986 patent/US7754702B2/en active Active
- 2007-01-08 EP EP13166988.9A patent/EP2626074A1/en not_active Withdrawn
- 2007-01-08 WO PCT/US2007/000176 patent/WO2007081744A2/en active Application Filing
- 2007-01-08 KR KR1020187018660A patent/KR20180077337A/ko not_active Application Discontinuation
- 2007-01-08 EP EP16172826.6A patent/EP3081219A1/en active Pending
- 2007-01-08 CN CN2007800020060A patent/CN101365458B/zh not_active Ceased
- 2007-01-08 KR KR1020087016352A patent/KR20080082674A/ko not_active Application Discontinuation
-
2009
- 2009-03-31 HK HK09103049.6A patent/HK1125044A1/xx not_active IP Right Cessation
-
2010
- 2010-05-25 US US12/787,283 patent/US8431549B2/en active Active
-
2013
- 2013-03-19 US US13/847,254 patent/US20130230565A1/en not_active Abandoned
- 2013-12-09 US US14/100,717 patent/US8895612B2/en active Active
-
2015
- 2015-04-10 US US14/683,415 patent/US10478450B2/en active Active
-
2016
- 2016-10-19 CY CY20161101047T patent/CY1118780T1/el unknown
-
2018
- 2018-04-20 US US15/958,930 patent/US11433091B2/en active Active
- 2018-11-15 US US16/192,681 patent/US11406656B2/en active Active
-
2019
- 2019-06-11 US US16/438,340 patent/US11478502B2/en active Active
-
2020
- 2020-03-20 US US16/825,121 patent/US11344568B2/en active Active
- 2020-03-20 US US16/825,337 patent/US11364260B2/en active Active
-
2022
- 2022-06-16 US US17/842,483 patent/US20230008240A1/en active Pending
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10478450B2 (en) | 2006-01-06 | 2019-11-19 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
US11478502B2 (en) | 2006-01-06 | 2022-10-25 | American Regent, Inc. | Methods and compositions for administration of iron |
US11433091B2 (en) | 2006-01-06 | 2022-09-06 | American Regent, Inc. | Methods and compositions for administration of iron |
US20150297630A1 (en) | 2006-01-06 | 2015-10-22 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
US11406656B2 (en) | 2006-01-06 | 2022-08-09 | American Regent, Inc. | Methods and compositions for administration of iron |
US11364260B2 (en) | 2006-01-06 | 2022-06-21 | American Regent, Inc. | Methods and compositions for administration of iron |
US11344568B2 (en) | 2006-01-06 | 2022-05-31 | American Regent, Inc. | Methods and compositions for administration of iron |
US10414831B2 (en) | 2009-03-25 | 2019-09-17 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
US10865255B2 (en) | 2009-03-25 | 2020-12-15 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
CN102947321A (zh) * | 2010-06-09 | 2013-02-27 | 倍尔福股份公司 | 铁与麦芽糖酸的新型低分子量配合物、其在治疗贫血症状中用于肌肉或皮下给药的应用以及适于该应用的新型药剂组合物 |
CN102153651A (zh) * | 2011-01-21 | 2011-08-17 | 厦门大学 | 抗葡聚糖单链抗体及其制备方法 |
CN102153651B (zh) * | 2011-01-21 | 2012-11-14 | 厦门大学 | 抗葡聚糖单链抗体及其制备方法 |
CN105708805A (zh) * | 2016-01-28 | 2016-06-29 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁及其制备方法 |
CN105708792A (zh) * | 2016-01-28 | 2016-06-29 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁注射液及其制备方法 |
CN105616372A (zh) * | 2016-01-28 | 2016-06-01 | 山西普德药业股份有限公司 | 一种还原型羧烷基葡聚糖铁片剂 |
CN105726569A (zh) * | 2016-03-02 | 2016-07-06 | 东南大学 | 聚糖超顺磁氧化铁在制备治疗心血管疾病药物方面的应用 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101365458B (zh) | 用于铁给药的方法和组合物 | |
CN105848661A (zh) | 用于预防或治疗铁缺乏的包含铁氧化物纳米颗粒的药物组合物 | |
AU2016205002B2 (en) | Methods and compositions for administration of iron | |
AU2013206429B2 (en) | Methods and compositions for administration of iron | |
ES2602433T3 (es) | Métodos y composiciones para la administración de hierro | |
US20110207680A1 (en) | Administration of Glufosfamide For The Treatment of Cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1125044 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1125044 Country of ref document: HK |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170329 Address after: St Gallen Patentee after: Vifor Int AG Address before: American New York Patentee before: Luitpold Pharm Inc. |
|
IW01 | Full invalidation of patent right | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20170712 Decision number of declaring invalidation: 31944 Granted publication date: 20120905 |